Synthesis and pharmacological evaluation of some novel potent type II antidiabetic agents

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn , Issue 1, 2009, Pages 149-158

  Velingkar, V S ^a   Dandekar, V D ^a   Murugananthan, K ^a  

^a PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

Author keywords

Glibenclamide analogs; Hypoglycemia; Sulfonylureas

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; N [4 [2 (1 CHLOROACETAMIDO)ETHYL]PHENYLSULFONYL] METHYL UREA; N [4 [2 (2 METHOXYBENZAMIDO)ETHYL]PHENYLSULFONYL] CYCLOHEXYL UREA; N [4 [2 (5 CHLORO 2 HYDROXYBENZAMIDO)ETHYL]PHENYLSULFONYL] CYCLOHEXYL UREA; N [4 [2 (5 CHLORO 2 METHOXYBENZAMIDO)ETHYL]PHENYLSULFONYL] CYCLOHEXYL UREA; N [4 [2 (5 CHLORO 2 METHOXYBENZAMIDO)ETHYL]PHENYLSULFONYL] METHYL UREA; N [4 [2 (BENZAMIDO)ETHYL]PHENYLSULFONYL] METHYL UREA; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIET RESTRICTION; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GLUCOSE BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT;

EID: 77953372280     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Amos AF, Mc Carty and Zimmet DJ. Diabetic Med.1997; 14 (5): 1.
2. Nielsen H, Hother NO, Pedersen O. Diabetic Med.1988; 5:613.
3. Pandey SN, NarayanMurti K. Eastern Pharmacist.1992; Aug: 71.
4. th Edn, Singapore: Pearson Education, 1978, p.138.
5. th Edn, Singapore: Pearson Education, 1978,p.157.
6. Biere H, Rufer C,Ahrens H, Loge O and Schroder E.J. Med. Chem.1974; 17(7):716.
7. Annamala PT,Augusti KT.Ind. J.Exp.Biol.1980; 18(8): 847.
8. Ponnachan PTC,Paulose CS and Pnikkar KR. Ind. J. Exp. Biol. 1993; 32:345.
9. Bernett RN, Cash AD. Amer. J. Clin. Path.1969; 52;457.
10. Orzeck EA, Mooney JH, Owen JA. Diabetes. 1971;20:109.